Congratulations! First In Vivo Treatment Study for Vulvovaginal Candidiasis Published in《Journal of Fungi》

JoyCom Group's patented feminine intimate care technology has been published in Journal of Fungi 2025 with the title "Dual Mechanisms of Action: Anti-Candida and Anti-Inflammatory Potential of
Lactobacillus Fermentation Broth in Treating Vulvovaginal Candidiasis."
The study demonstrates, for the first time in an animal model, effective inhibition of Candida albicans infection and associated inflammatory responses, offering a promising alternative to traditional treatments.

We will continue our commitment to medical research and innovation.
Thank you for your ongoing support and trust!